COST

1,010.1

+1.84%↑

PG

162.42

+2.84%↑

KO

71.62

+3.6%↑

PM

169.23

+3.24%↑

PEP

131.4

+2.3%↑

COST

1,010.1

+1.84%↑

PG

162.42

+2.84%↑

KO

71.62

+3.6%↑

PM

169.23

+3.24%↑

PEP

131.4

+2.3%↑

COST

1,010.1

+1.84%↑

PG

162.42

+2.84%↑

KO

71.62

+3.6%↑

PM

169.23

+3.24%↑

PEP

131.4

+2.3%↑

COST

1,010.1

+1.84%↑

PG

162.42

+2.84%↑

KO

71.62

+3.6%↑

PM

169.23

+3.24%↑

PEP

131.4

+2.3%↑

COST

1,010.1

+1.84%↑

PG

162.42

+2.84%↑

KO

71.62

+3.6%↑

PM

169.23

+3.24%↑

PEP

131.4

+2.3%↑

Search

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

6.72 0.45

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

6.45

Max

6.72

Schlüsselkennzahlen

By Trading Economics

Einkommen

-8.2M

-15M

Verkäufe

2.6M

35M

KGV

Branchendurchschnitt

201.137

42.52

EPS

-0.253

Gewinnspanne

-42.012

Angestellte

524

EBITDA

-5.5M

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

62M

236M

Vorheriger Eröffnungskurs

6.27

Vorheriger Schlusskurs

6.72

Nachrichtenstimmung

By Acuity

13%

87%

8 / 151 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Mai 2025, 23:40 UTC

Heiße Aktien

Stocks to Watch: UnitedHealth Group, Foot Locker, CoreWeave

14. Mai 2025, 23:33 UTC

Wichtige Markttreiber

UnitedHealth Group Shares Fall After WSJ Reports of Investigation for Possible Medicare Fraud

14. Mai 2025, 23:25 UTC

Wichtige Markttreiber

Biohaven Shares Down as FDA Extends PDUFA Data for Troriluzole

14. Mai 2025, 23:25 UTC

Ergebnisse

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth -- Update

14. Mai 2025, 22:58 UTC

Ergebnisse

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth

14. Mai 2025, 21:35 UTC

Ergebnisse

Cisco Systems Names Patterson as CFO, Patel as President

14. Mai 2025, 23:59 UTC

Market Talk

Implications of Xero's Cost Outlook Aren't Clear -- Market Talk

14. Mai 2025, 23:49 UTC

Market Talk

Xero's Cost Outlook Likely to Prompt Downgrades -- Market Talk

14. Mai 2025, 23:48 UTC

Market Talk

Global Equities Roundup: Market Talk

14. Mai 2025, 23:48 UTC

Market Talk

Nikkei May Decline on Profit-Taking After Recent Gains -- Market Talk

14. Mai 2025, 23:47 UTC

Market Talk

Gold Gains on Possible Technical Recovery -- Market Talk

14. Mai 2025, 23:34 UTC

Akquisitionen, Fusionen, Übernahmen

Agnico-Eagle Mines to Subscribe for 30M Voting Common Shares of Foran Mining in Non-Brokered Private Placement at C$3 a Share

14. Mai 2025, 23:10 UTC

Ergebnisse

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth -- Update

14. Mai 2025, 23:07 UTC

Ergebnisse

CoreWeave Posts Strong Revenue and Wins Google as a Customer. Stock Still Dives on Outlook. -- Barrons.com

14. Mai 2025, 23:00 UTC

Top News

UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud -- WSJ

14. Mai 2025, 22:43 UTC

Ergebnisse

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth

14. Mai 2025, 22:34 UTC

Ergebnisse

Xero Expects 1H Operating Expense Ratio to Be Higher Than 2H>XRO.AU

14. Mai 2025, 22:33 UTC

Ergebnisse

Xero Expects FY26 Operating Expense Ratio of 71.5%>XRO.AU

14. Mai 2025, 22:30 UTC

Ergebnisse

Xero Did Not Declare a Dividend>XRO.AU

14. Mai 2025, 22:30 UTC

Ergebnisse

Xero FY Operating Expenses 71.8% of Operating Revenue Vs. 73.3%>XRO.AU

14. Mai 2025, 22:30 UTC

Ergebnisse

Xero FY Free Cashflow Margin 24.1% Vs. 20.0%>XRO.AU

14. Mai 2025, 22:30 UTC

Ergebnisse

Xero FY Free Cashflow NZD506.7M Vs. NZD342.1M>XRO.AU

14. Mai 2025, 22:28 UTC

Ergebnisse

Xero FY Ebitda NZD638.5M Vs. NZD497.4M>XRO.AU

14. Mai 2025, 22:28 UTC

Ergebnisse

Xero FY Adjusted Ebitda NZD640.6M Vs. NZD526.5M>XRO.AU

14. Mai 2025, 22:27 UTC

Ergebnisse

Xero FY Rev NZD2.10B Vs. NZD1.71B >XRO.AU

14. Mai 2025, 22:27 UTC

Ergebnisse

Xero FY Net NZD227.8M Vs. Net NZD174.6M >XRO.AU

14. Mai 2025, 22:23 UTC

Top News

Boeing, GE Aerospace Get Qatar Airways Order After Saudi AI Tech Deals -- 2nd Update

14. Mai 2025, 22:15 UTC

Ergebnisse

Correction to Cisco Earnings Article -- WSJ

14. Mai 2025, 21:48 UTC

Ergebnisse

CoreWeave Posts Strong Revenue but Stock Dives on Updated Outlook -- Barrons.com

14. Mai 2025, 21:37 UTC

Ergebnisse

Cisco Reports Solid Earnings. The Stock Is Rising. -- Barrons.com

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Rating-Konsens

By TipRanks

Buy

2 ratings

1

Buy

1

Halten

0

Sell

Stimmung

By Acuity

8 / 151 Ranking in Konsumgüter defensiv

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.